Company Filing History:
Years Active: 2023-2025
Title: Innovations of Jinchao Weng in Pharmaceutical Chemistry
Introduction
Jinchao Weng is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of prodrugs. With a total of two patents to his name, Weng's work focuses on enhancing the efficacy and purity of pharmaceutical compounds.
Latest Patents
Weng's latest patents include a method of preparing a DON prodrug from L-glutamic acid. This patent details a process for creating a compound of Formula (I) with over 95% chemical purity and enantiomeric excess. Another significant patent involves a method of preparing a DON prodrug from L-pyroglutamic acid, which also achieves over 95% chemical purity and enantiomeric excess for the compound of Formula I.
Career Highlights
Jinchao Weng is currently associated with Dracen Pharmaceuticals, Inc., where he applies his expertise in drug development. His innovative approaches have the potential to impact the pharmaceutical industry significantly.
Collaborations
Weng collaborates with esteemed colleagues such as Jon Philip Lawson and Robert Christian Wild. Their combined efforts contribute to advancing research and development in the pharmaceutical sector.
Conclusion
Jinchao Weng's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to improving drug efficacy and safety. His work continues to influence the field positively.